Concern in the Greek pharmaceutical market due to company departures
Significant turmoil has been prevailing in the Greek pharmaceutical sector recently. Many multinational pharmaceutical companies have announced their decision to limit their operations in the country or even withdraw completely from the Greek market.
This development has caused intense concern among employees in the sector, as these changes are accompanied by staff layoffs. Employee representatives are expressing their fears regarding the future of jobs, as the crisis in the sector appears to be deepening.
At the same time, there is concern regarding patient access to new and essential medications. Experts point out that the departure of large companies may make it difficult to introduce innovative drugs in Greece, directly affecting the quality of healthcare.
The competent authorities are closely monitoring developments, trying to understand the causes of this crisis. The goal is to find solutions that will ensure both the smooth operation of the market and the uninterrupted supply of medicines to citizens.